Switzerland’s ABB, Shanghai Hospital to Build First Smart Pharmacy

Life Science

NovoCodex Acquires China Rights to Second Ambrx ADC Candidate

Life Science

Verseau Therapeutics Launches with $50 Million to Reprogram Immune Cells to Treat Cancer

Life Science

Merck Opens Shanghai Innovation Hub with $14 Million for China Startups

Life Science

Exegenesis Bio Closes $10 Million Initial Funding from China Investors

Life Science

Taimei Technology Raises $212 Million to Advance CRO/Life Science Software

Life Science

Eisai Approved to Launch Antiepileptic Drug in China

Life Science

dMed Biopharma, a China, US, EU Clinical CRO, Raises $50 Million

Life Science

San Diego’s Ansun Bio Closes $80 Million B Round from China Investors for Novel Antiviral

Life Science

Kangpu Completes Phase I Trial of Cancer Immunomodulator

Life Science

Harbour BioMed Completes China Phase II Trial of Dry Eye Treatment

Life Science

BJ Bio Selects CMAB for CMC and Manufacturing of Cancer mAb

Life Science

Innovent and Chi-Med Add Second Chi-Med Drug to Combo Partnership

Life Science

China Grand Pharma Pays $30 Million for Majority Stake in US-Based OncoSec

Life Science

Chenguang Biotech to Build USD30 Million Tomato Processing Plant in California

Life Science